Jonathan Smith

Leap Therapeutics has merged with Flame Biosciences to get its targeted oncology pipeline, including antibodies targeting Claudin18.2.

The nearly 100-year-old skater favorite will be retired for a new model next year.

Here are biotech companies to watch in 2023. Adaptimmune Therapeutics • Argenx • Axsome Therapeutics • BioArctic • Galapagos • InSilico

Green Bioactives devises eco-friendly ways to produce plant-derived pharmaceuticals via plant cell cultures.

The EU’s regulations around advanced therapy medicinal products (ATMPs) should change to keep Europe competitive with the rest of the world.

The founding team behind Sibylla Biotech explains how their interdisciplinary approach can speed up drug discovery.

Nagi Bioscience aims to speed up drug and chemical safety testing by automating research on a worm called Caenorhabditis elegans.

Check out five of the biotech startup companies causing a stir in Brazil: Autem Medical • Decoy Smart Control • Gen-t • InEdita Bio • Vyro Bio

The newly launched scaling service provider Boston Bioworks aims to address the bottleneck in scaling up precision fermentation.

Technology transfer offices are vital for commercializing biotech innovations, but many must streamline their process to land more deals.